Theravance Biopharma, Inc. (TBPH)
NASDAQ: TBPH · Real-Time Price · USD
9.23
-0.08 (-0.86%)
Mar 28, 2025, 4:00 PM EDT - Market closed
Theravance Biopharma Employees
Theravance Biopharma had 97 employees as of December 31, 2024. The number of employees decreased by 2 or -2.02% compared to the previous year.
Employees
97
Change (1Y)
-2
Growth (1Y)
-2.02%
Revenue / Employee
$663,722
Profits / Employee
-$581,629
Market Cap
456.61M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 92,900 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
TBPH News
- 1 day ago - Theravance Biopharma to Present New Ampreloxetine Analyses in Neurogenic Orthostatic Hypotension (nOH) at the 77th Annual Meeting of the American Academy of Neurology - PRNewsWire
- 4 weeks ago - Theravance Biopharma, Inc. (TBPH) Q4 2024 Earnings Call Transcript - Seeking Alpha
- 4 weeks ago - Theravance Biopharma, Inc. Reports Record Fourth Quarter and Full Year 2024 Financial Results - PRNewsWire
- 5 weeks ago - Theravance Biopharma to Participate in an Upcoming Investor Conference - PRNewsWire
- 6 weeks ago - Theravance Biopharma to Report Fourth Quarter and Full Year 2024 Financial Results on February 26, 2025 - PRNewsWire
- 3 months ago - Theravance Biopharma to Conduct Investor Meetings During the J.P. Morgan 43rd Annual Healthcare Conference - PRNewsWire
- 4 months ago - Theravance Biopharma, Inc. (TBPH) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 4 months ago - Theravance Biopharma, Inc. Reports Third Quarter 2024 Financial Results and Announces Initiatives to Unlock Shareholder Value - PRNewsWire